(VELA) Study of BLU-222 in Advanced Solid Tumors

Clinical trial NCT05252416 · TERMINATED

Trial details

NCT number: NCT05252416
Sponsor: Blueprint Medicines Corporation
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors HR+ Breast Cancer CCNE1 Amplification HER2-negative Breast Cancer Ovarian Cancer Endometrial Cancer Gastric Cancer Esophageal Adenocarcinoma Carcinosarcoma

Start date: 2022-04-07
Primary completion: 2025-07-04
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.